NASDAQ:NEOT
Delisted

Neothetics Fund Forecast

$1.92
+0 (+0%)
At Close: Feb 01, 2018
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.

Red day on Thursday for Neothetics fund after losing 0%
(Updated on Feb 01, 2018)

Buy or Hold candidate since Oct 13, 2017 Gain 47.64% PDF

No changes to the price of Neothetics fund on the last trading day (Thursday, 1st Feb 2018). During the last trading day the fund fluctuated 0% from a day low at $1.92 to a day high of $1.92. The price has been going up and down for this period, and there has been a 0% change for the last 2 weeks.

The fund lies in the lower part of a very wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $1.86 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the fund is expected to rise 60.99% during the next 3 months and, with a 90% probability hold a price between $2.99 and $3.91 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

NEOT Signals & Forecast

The Neothetics fund holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $1.92 and $1.86. A breakdown below any of these levels will issue sell signals. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Wednesday, January 31, 2018, and so far it has fallen 0%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Neothetics fund

On the downside, the fund finds support just below today's level from accumulated volume at $1.64 and $1.50. There is a natural risk involved when a fund is testing a support level, since if this is broken, the fund then may fall to the next support level. In this case, Neothetics finds support just below today's level at $1.64. If this is broken, then the next support from accumulated volume will be at $1.50 and $1.45.

In general the fund tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the fund During the last day, the fund moved $0 between high and low, or 0%. For the last week the fund has had daily average volatility of 0%

Our recommended stop-loss: $1.84 (-4.06%) (This fund has low daily movements and this gives low risk. There is a sell signal from a pivot top found 1 day ago.)

Trading Expectations (NEOT) For The Upcoming Trading Day Of Friday 2nd

For the upcoming trading day on Friday, 2nd we expect Neothetics to open at $1.92, and during the day (based on 14 day Average True Range), to move between $1.87 and $1.97, which gives a possible trading interval of +/-$0.0517 (+/-2.69%) up or down from last closing price. If Neothetics takes out the full calculated possible swing range there will be an estimated 5.38% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $2.03 (5.77%) than the support at $1.64 (14.55%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Neothetics fund A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Neothetics fund to perform well in the short-term.

Current score: 3.040 Buy Candidate Unchanged

Predicted Opening Price for Neothetics of Friday, February 2, 2018

Fair opening price February 2, 2018 Current price
$1.92 ( 0%) $1.92

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for NEOT

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 1.92 .
R2 1.92 .
R1 1.92 .
Current price: 1.92
Support S1 1.92 .
S2 1.92 .
S3 1.92 .

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 2.08 8.37 %
R2 2.06 7.33 %
R1 2.03 5.77 %
Current price 1.92
Support S1 1.64 -14.55%
S2 1.50 -21.85%
S3 1.45 -24.45%

FAQ

What is the symbol for Neothetics Fund and on which exchange is it traded?
The symbol for Neothetics is NEOT and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Neothetics Fund?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Neothetics fund to perform well in the short-term.

How to buy Neothetics Fund?
Neothetics Fund can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Neothetics Fund.

What's the current price of Neothetics Fund?
As of the end of day on the 2018-02-01, the price of an Neothetics (NEOT) share was $1.92.

What is the 52-week high and low for Neothetics Fund?
The 52-week high for Neothetics Fund is $2.63 and the 52-week low is $0.300.
Click to get the best stock tips daily for free!

About Neothetics

Neothetics, Inc., a clinical-stage specialty pharmaceutical company, develops therapeutics for the aesthetic market. Its lead product candidate is LIPO-202, an injectable formulation of salmeterol xinafoate for the reduction of central abdominal bulging due to subcutaneous fat in non-obese patients, as well as for the reduction of unwanted localized fat deposits under the chin or submental fat. The company was formerly known as Lipothera, Inc. an... NEOT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT